Literature DB >> 18998457

[Candidate targets for research on benign prostatic hyperplasia].

Zhen-Feng Hong1.   

Abstract

The etiology and pathogenesis of benign prostatic hyperplasia are very complicated, about which a variety of theories have been developed, so it is of utmost importance to decide upon the target of research. Focusing on the pathogenesis of benign prostatic hy-perplasia, the author outlines the candidate targets for the experimental studies of the disease in such approaches as morphology, hormones, growth factors and genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998457

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  1 in total

1.  Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.

Authors:  Jiumao Lin; Jianheng Zhou; Wei Xu; Xiaoyong Zhong; Zhenfeng Hong; Jun Peng
Journal:  Exp Ther Med       Date:  2013-03-15       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.